Correction to “Dermatological Manifestations in the Intensive Care Unit of a Third‐Level Hospital”
JEADV Clinical Practice, EarlyView.
wiley +1 more source
Treatment of Aggressive Antineutrophil Cytoplasmic Antibody–Associated Vasculitis With Eculizumab
Kidney International Reports, 2020 Noah Huizenga +5 more
doaj
Platelet releasing activity in sera of patients with rheumatoid vasculitis. [PDF]
, 1986 Timothy J. Cunningham +3 more
openalex +1 more source
Infective endocarditis mimicking antineutrophil-cytoplasmic-antibody-associated vasculitis with glomerulonephritis: a case report. [PDF]
J Med Case RepMatarneh A +8 more
europepmc +1 more source
Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors
British Journal of Pharmacology, EarlyView.Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen +3 more
wiley +1 more source
Studies on the blood fibrinolytic enzyme system of patients with cutaneous vasculitis [PDF]
, 1980 Naotika Toki, T Yamura
openalex +1 more source
Clinical &Experimental Allergy, EarlyView.Chronic spontaneous urticaria (CSU) is a debilitating skin disorder with significant impact upon quality of life. Current guidelines advocate stepwise treatment of standard dose antihistamines, high dose antihistamines, omalizumab and ciclosporin.
Katie Ridge +7 more
wiley +1 more source
Clinical observation on collagen disease as vasculitis, including current 4 cases
, 1976 Takehide Takuma, Nobuhiro Sugino
openalex +2 more sources
Simultaneous Finding of Diabetic Glomerulosclerosis and Macroscopic PAN-Type Necrotising Vasculitis in the Same Patient [PDF]
, 1985 Joan Fort
openalex +1 more source